8-K - Summit Therapeutics Inc. (0001599298) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Summit Therapeutics filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
Directly affected
- SMMT Summit Therapeutics
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Summit Therapeutics belongs to, so it often moves with news about it.
- LLY Eli Lilly and
Eli Lilly and is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson
Johnson & Johnson is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie
AbbVie is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck
Merck is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories
Abbott Laboratories is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| SMMT | +26.12% | +17.57% | base | after close | after close | after close | after close |
| XLV | -0.28% | +0.04% | base | after close | after close | after close | after close |
| LLY | -2.25% | -0.49% | base | after close | after close | after close | after close |
| JNJ | -1.35% | -1.97% | base | after close | after close | after close | after close |
| ABBV | -0.57% | -0.04% | base | after close | after close | after close | after close |
| MRK | +0.65% | -0.38% | base | after close | after close | after close | after close |
| ABT | +1.85% | +0.80% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-16 AccNo: 0001599298-26-000092 Size: 1 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Summit Therapeutics (SMMT) has moved since 16 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| AbbVie (ABBV) | three days earlier | -0.04% | final price |
| AbbVie (ABBV) | five days earlier | -0.57% | final price |
| Abbott Laboratories (ABT) | three days earlier | +0.80% | final price |
| Abbott Laboratories (ABT) | five days earlier | +1.85% | final price |
| Johnson & Johnson (JNJ) | three days earlier | -1.97% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -1.35% | final price |
| Eli Lilly (LLY) | three days earlier | -0.49% | final price |
| Eli Lilly (LLY) | five days earlier | -2.25% | final price |
| Merck (MRK) | three days earlier | -0.38% | final price |
| Merck (MRK) | five days earlier | +0.65% | final price |
| Summit Therapeutics (SMMT) | three days earlier | +17.57% | final price |
| Summit Therapeutics (SMMT) | five days earlier | +26.12% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | +0.04% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -0.28% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 13 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 27 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 73 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 40 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 47 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 52 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 40 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 63 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 73 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 89 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 40 days before publication. Filed 5 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Summit Therapeutics (SMMT)
Companies carried with this story
- SMMT Summit Therapeutics
Summit Therapeutics (SMMT) is linked, with no stored direction, high confidence in the 16 Nov 2026 story “8-K - Summit Therapeutics Inc. (0001599298) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> SMMT
- XLV Select Sector Spdr Tr
Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Summit Therapeutics Inc. (0001599298) (Filer).” Reason on file: Health Care Select Sector SPDR holds the health sector that Summit Therapeutics belongs to, so it often moves with news about it
- LLY Eli Lilly
Eli Lilly (LLY) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Summit Therapeutics Inc. (0001599298) (Filer).” Reason on file: Eli Lilly and is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news
- JNJ Johnson & Johnson
Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Summit Therapeutics Inc. (0001599298) (Filer).” Reason on file: Johnson & Johnson is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news
- ABBV AbbVie
In “8-K - Summit Therapeutics Inc. (0001599298) (Filer),” AbbVie (ABBV) is linked, with no stored direction, medium confidence. Reason on file: AbbVie is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news
- MRK Merck
In “8-K - Summit Therapeutics Inc. (0001599298) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news
- ABT Abbott Laboratories
Abbott Laboratories (ABT) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Summit Therapeutics Inc. (0001599298) (Filer).” Reason on file: Abbott Laboratories is a peer of Summit Therapeutics in pharmaceutical preparations; rivals often move on the same news
How “8-K - Summit Therapeutics Inc. (0001599298) (Filer)” reaches Summit Therapeutics (SMMT)
The 16 Nov 2026 story “8-K - Summit Therapeutics Inc. (0001599298) (Filer)” names Summit Therapeutics (SMMT) because of this story.
Summit Therapeutics (SMMT) is on the page because SEC 8-K filing -> direct issuer disclosure -> SMMT
Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR holds the health sector that Summit Therapeutics belongs to, so it often moves with news about it
Price levels for Summit Therapeutics (SMMT)
LLY traded between 1239.21 and 1458.90 across 20 sessions. The latest close on file is 1430.09. SMMT traded between 14.17 and 18.14 across 8 sessions. The latest close on file is 15.07.
How strong the case is around Summit Therapeutics (SMMT)
46 out of 100
“8-K - Summit Therapeutics Inc. (0001599298) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.